The UK Government is to announce at the ABPI Conference that the most promising treatments will be fast-tracked by the new and boosted Accelerated Access Collaborative.
The ABPI welcomes the move that means that medicines, technologies and diagnostic tools targeting key health problems will be prioritised.
Speaking ahead of the conference, ABPI CEO, Mike Thompson, said: “This is a real step forward in making sure UK patients get the latest breakthrough treatments. It sends a clear message that the UK intends to build an innovation-led economy alongside a more productive, innovation-ready NHS.
“We fully support Sam Roberts in making this a huge success that will change the lives of patients in the UK.’